Consolidated Statement Of Income

D.Western Therapeutics Institute, Inc. - Filing #7586205

Concept 2022-01-01 to
2022-09-30
2021-01-01 to
2021-09-30
Consolidated statement of income
Statement of income
Net sales
309,158,000 JPY
315,893,000 JPY
Operating expenses
Selling, general and administrative expenses
541,671,000 JPY
415,820,000 JPY
Other
190,201,000 JPY
187,694,000 JPY
Operating expenses
Cost of sales
19,008,000 JPY
14,441,000 JPY
Net sales
Gross profit (loss)
290,149,000 JPY
301,451,000 JPY
Operating profit (loss)
-251,521,000 JPY
-114,369,000 JPY
Ordinary profit (loss)
-239,408,000 JPY
-105,915,000 JPY
Operating expenses
Research and development expenses
351,470,000 JPY
228,125,000 JPY
Non-operating income
Interest income
25,000 JPY
21,000 JPY
Other
1,008,000 JPY
368,000 JPY
Non-operating income
38,789,000 JPY
13,255,000 JPY
Selling, general and administrative expenses
Cost of sales
Non-operating expenses
Interest expenses
2,465,000 JPY
3,440,000 JPY
Other
JPY
111,000 JPY
Non-operating expenses
26,677,000 JPY
4,801,000 JPY
Share issuance costs
JPY
1,168,000 JPY
Profit (loss) before income taxes
-239,408,000 JPY
-105,915,000 JPY
Gross profit
Income taxes - current
1,196,000 JPY
1,196,000 JPY
Income taxes
1,196,000 JPY
1,196,000 JPY
Profit (loss)
-240,605,000 JPY
-107,112,000 JPY
Profit (loss) attributable to non-controlling interests
-14,138,000 JPY
-5,201,000 JPY
Profit (loss) attributable to owners of parent
-226,467,000 JPY
-101,910,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-338,000 JPY
JPY
Other comprehensive income
-338,000 JPY
JPY
Profit attributable to
Comprehensive income
-240,943,000 JPY
-107,112,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-226,805,000 JPY
-101,910,000 JPY
Comprehensive income attributable to non-controlling interests
-14,138,000 JPY
-5,201,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.